Human T-lymphotropic virus 1 neurologic disease (Q38878539)

7 September 2017

Human T-lymphotropic virus 1 neurologic disease (English)

1 reference

Human T-lymphotropic virus 1

7 September 2017

0 references

author name string

Abelardo Araújo

series ordinal

1

1 reference

PubMed ID

18579023

7 September 2017

Marco Antonio Lima

series ordinal

2

1 reference

PubMed ID

18579023

7 September 2017

Marcus Tulius T Silva

series ordinal

3

1 reference

7 September 2017

1 May 2008

1 reference

Current treatment options in neurology

7 September 2017

1 reference

7 September 2017

10

1 reference

7 September 2017

193-200

1 reference

7 September 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1007/s11940-008-0021-1

7 September 2017

0 references

cites work

Interferon-alpha is effective in HTLV-I-associated myelopathy: a multicenter, randomized, double-blind, controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS11940-008-0021-1

High-dose zidovudine induction in HTLV-I-associated myelopathy: safety and possible efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-008-0021-1

Danazol a new perspective in the treatment of htlv-l associated myelopathy (preliminary report)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-008-0021-1

Green tea polyphenols induce apoptosis in vitro in peripheral blood T lymphocytes of adult T-cell leukemia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-008-0021-1

Augmentation of mouse natural killer cell activity by Lactobacillus casei and its surface antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-008-0021-1

The HTLV-1 neurological complex

21 January 2018

1 reference

12 December 2020

Going with the flow: methotrexate, adenosine, and blood flow

1 reference

12 December 2020

A prospective uncontrolled trial of fermented milk drink containing viable Lactobacillus casei strain Shirota in the treatment of HTLV-1 associated myelopathy/tropical spastic paraparesis

1 reference

12 December 2020

The effect of zidovudine on chronic myelopathy associated with HTLV-1

1 reference

12 December 2020

Antiviral effect of zidovudine in the experimental model of adult T cell leukemia in rabbits

1 reference

12 December 2020

Tropical Spastic Paraparesis/HTLV-1-Associated Myelopathy (TSP/HAM): Treatment with an Anabolic Steroid Danazol

1 reference

12 December 2020

Human T lymphotropic virus type 1 (HTLV-1) proviral load in asymptomatic carriers, HTLV-1-associated myelopathy/tropical spastic paraparesis, and other neurological abnormalities associated with HTLV-1 infection

1 reference

12 December 2020

HTLV-1 provirus load in peripheral blood lymphocytes of HTLV-1 carriers is diminished by green tea drinking

1 reference

12 December 2020

Manifestations of the human T-cell lymphotropic virus type I infection in childhood and adolescence

1 reference

12 December 2020

Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/ tropical spastic paraparesis

1 reference

12 December 2020

Intravenous methylprednisolone in HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP).

1 reference

12 December 2020

Interferon-beta1a therapy in human T-lymphotropic virus type I-associated neurologic disease

1 reference

12 December 2020

Pentoxifylline treatment in HTLV-I-associated myelopathy.

1 reference

12 December 2020

Zidovudine plus lamivudine in Human T-Lymphotropic Virus type-I-associated myelopathy: a randomised trial

1 reference

12 December 2020

Long-term, high dose interferon-alpha treatment in HTLV-I-associated myelopathy/tropical spastic paraparesis: a combined clinical, virological and immunological study

1 reference

12 December 2020

Histone deacetylase mediated transcriptional activation reduces proviral loads in HTLV-1 associated myelopathy/tropical spastic paraparesis patients

1 reference

12 December 2020

Successful application of pentoxifylline in the treatment of HTLV-I associated myelopathy.

1 reference

12 December 2020

Clinical and neuropathological study of six patients with spastic paraparesis associated with HTLV-I: an axomyelinic degeneration of the central nervous system.

1 reference

12 December 2020

Juvenile human T lymphotropic virus type 1-associated myelopathy

1 reference

12 December 2020

Effect of lamivudine on human T-cell leukemia virus type 1 (HTLV-1) DNA copy number, T-cell phenotype, and anti-tax cytotoxic T-cell frequency in patients with HTLV-1-associated myelopathy

1 reference

12 December 2020

Systemic interferon-alpha in the treatment of HTLV-I-associated myelopathy

1 reference

12 December 2020

Infiltration of helper/inducer T lymphocytes heralds central nervous system damage in human T-cell leukemia virus infection

1 reference

12 December 2020

10.1007/S11940-008-0021-1

Identifiers

DOI

1 reference

7 September 2017

1 reference

PubMed ID

18579023